Substance use patterns and HIV-1 RNA viral load rebound among HIV-positive illicit drug users in a Canadian setting

F Ladak, E Socias, S Nolan, H Dong, T Kerr… - Antiviral …, 2019 - journals.sagepub.com
Background Active illicit drug use can present a barrier to the medical management of HIV
infection by complicating adherence to antiretroviral therapy (ART). Plasma HIV-1 RNA viral …

[HTML][HTML] SUBSTANCE USE PATTERNS AND HIV-1 RNA VIRAL LOAD REBOUND AMONG HIV-POSITIVE ILLICIT DRUG USERS IN A CANADIAN SETTING

F Ladak, E Socias, S Nolan, H Dong, T Kerr… - Antiviral …, 2019 - ncbi.nlm.nih.gov
Background: Active illicit drug use can present a barrier to the medical management of HIV
infection by complicating adherence to antiretroviral therapy (ART). Plasma HIV-1 RNA viral …

Substance use patterns and HIV-1 RNA viral load rebound among HIV-positive illicit drug users in a Canadian setting.

F Ladak, E Socias, S Nolan, H Dong, T Kerr… - Antiviral …, 2019 - europepmc.org
Background Active illicit drug use can present a barrier to the medical management of HIV
infection by complicating adherence to antiretroviral therapy (ART). Plasma HIV-1 RNA viral …

Substance use patterns and HIV-1 RNA viral load rebound among HIV-positive illicit drug users in a Canadian setting

F Ladak, E Socias, S Nolan, H Dong… - Antiviral …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Active illicit drug use can present a barrier to the medical management of HIV
infection by complicating adherence to antiretroviral therapy (ART). Plasma HIV-1 RNA viral …

Substance use patterns and HIV-1 RNA viral load rebound among HIV-positive illicit drug users in a Canadian setting.

F Ladak, E Socias, S Nolan, H Dong, T Kerr… - Antiviral …, 2019 - europepmc.org
Background Active illicit drug use can present a barrier to the medical management of HIV
infection by complicating adherence to antiretroviral therapy (ART). Plasma HIV-1 RNA viral …